Telemus Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-2,267
| Closed | -$785K | – | 352 |
|
2021
Q2 | $785K | Sell |
2,267
-241
| -10% | -$83.5K | 0.06% | 203 |
|
2021
Q1 | $697K | Buy |
2,508
+223
| +10% | +$62K | 0.05% | 239 |
|
2020
Q4 | $560K | Buy |
2,285
+701
| +44% | +$172K | 0.04% | 244 |
|
2020
Q3 | $444K | Buy |
+1,584
| New | +$444K | 0.03% | 324 |
|
2019
Q2 | – | Sell |
-974
| Closed | -$230K | – | 373 |
|
2019
Q1 | $230K | Buy |
+974
| New | +$230K | 0.02% | 381 |
|
2018
Q4 | – | Sell |
-680
| Closed | -$240K | – | 422 |
|
2018
Q3 | $240K | Buy |
+680
| New | +$240K | 0.02% | 397 |
|
2018
Q1 | – | Sell |
-230
| Closed | -$73K | – | 422 |
|
2017
Q4 | $73K | Buy |
+230
| New | +$73K | 0.01% | 419 |
|